Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Endris

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Blood Cancer Journal|August 23, 2014
KIT mutations in primary mediastinal B-cell lymphomaP D Nagel, A Stenzinger, F M Feld, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 18, 2021
ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical researchC Belli, F Penault-Llorca, M Ladanyi, et al.
NPJ Precision Oncology|June 10, 2022
Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD)E Rempel, K Kluck, S Beck, et al.
International Journal of Cancer|September 27, 2018
Identification of a highly lethal V3<sup>+</sup> TP53<sup>+</sup> subset in ALK<sup>+</sup> lung adenocarcinomaP Christopoulos, M Kirchner, F Bozorgmehr, et al.
ESMO Open|September 6, 2021
The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinomaM Kirchner, K Kluck, R Brandt, et al.
European Journal of Cancer (Oxford, England : 1990)|February 22, 2016
Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiationI Tinhofer, V Budach, M Saki, et al.
Virchows Archiv : an International Journal of Pathology|January 28, 2018
Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnosticsB Hirsch, V Endris, S Lassmann, et al.
Lung Cancer (Amsterdam, Netherlands)|September 2, 2020
Risk stratification of EGFR<sup>+</sup> lung cancer diagnosed with panel-based next-generation sequencingP Christopoulos, M Kirchner, J Roeper, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2022
Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancersA Jahn, A Rump, T J Widmann, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Blood Cancer Journal|August 23, 2014
KIT mutations in primary mediastinal B-cell lymphomaP D Nagel, A Stenzinger, F M Feld, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 18, 2021
ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical researchC Belli, F Penault-Llorca, M Ladanyi, et al.
NPJ Precision Oncology|June 10, 2022
Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD)E Rempel, K Kluck, S Beck, et al.
International Journal of Cancer|September 27, 2018
Identification of a highly lethal V3<sup>+</sup> TP53<sup>+</sup> subset in ALK<sup>+</sup> lung adenocarcinomaP Christopoulos, M Kirchner, F Bozorgmehr, et al.
ESMO Open|September 6, 2021
The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinomaM Kirchner, K Kluck, R Brandt, et al.
European Journal of Cancer (Oxford, England : 1990)|February 22, 2016
Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiationI Tinhofer, V Budach, M Saki, et al.
Virchows Archiv : an International Journal of Pathology|January 28, 2018
Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnosticsB Hirsch, V Endris, S Lassmann, et al.
Lung Cancer (Amsterdam, Netherlands)|September 2, 2020
Risk stratification of EGFR<sup>+</sup> lung cancer diagnosed with panel-based next-generation sequencingP Christopoulos, M Kirchner, J Roeper, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2022
Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancersA Jahn, A Rump, T J Widmann, et al.
Pageof 2